Under the terms of the agreement, EMD Serono will be responsible for promotion, distribution, and patient support services and Ipsen will retain ownership of the product. The agreement
In European studies, Esmya has been shown to be an effective and safe treatment for uterine fibroids (myoma). The product is currently in late stage development in Europe
A-CUBE is a venture capital-backed company funded by JAIC and yet2.com, which uses proprietary in silico algorithms to predict and monetize novel drug targets related to blockbuster drugs.
Through the partnership, the NextGen integrated technology platform will connect the Wills Eye community, giving care providers access to electronic health records and enabling exchange of patient data
In Australia, Aspen and Sigma‘s Pharmaceutical Division compete in a number of pharmaceutical markets, including in the supply of various prescription generic medicines and over-the-counter pharmaceutical products. In
Generex claims that the new Canadian Patent no. 2,354,148 titled Aerosol Formulations for Buccal and Pulmonary Application increases the number of issued patents related to the its buccal
Repligen claims that RG3039 is an inhibitor of an RNA processing enzyme which targets increased production of SMN, a protein of deficient levels in patients with SMA. The
Achievement of the milestone has entitled Envoy to receive a cash payment from Merck. The milestone was linked to Envoy successfully applying its bacTRAP technology in certain tissues
E7040 is a hydrophilic microspherical particle produced from a polyvinyl alcohol polymer. Eisai said that E7040 is an embolic bead that is injected through a catheter to physically
A-623 will be manufactured in the Billingham, UK facility of the network. Anthera Pharma has previously begun enrollment in Pearl-SC, a Phase 2b clinical study in Lupus patients,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.